Skip to content
BALCAO · WHOLESALE-APPAREL, PIECE GOODS & NOTIONS · SMALL CAP

VitaNova Life Sciences Corp. VNOV

10 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.0M
▲ 13.7% YoY
$-37,304
▼ 104.4% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

We are a U.S. focused consumer health, beauty and lifestyle company that develops, acquires, markets and sells branded nutritional supplements, functional beverages and complementary lifestyle products. Our dietary supplement operations are consolidated and commercialized through NutriPeak Trading Corporation (“NTC”), a wholly owned subsidiary formed in November 2023. Our consumer-health operations are managed through a dual-brand structure consisting of GeneCode® and AMZ®. The Company’s dual-brand system combines a science-oriented platform with a high-volume functional-nutrition line. In addition to developing and selling nutritional supplements under our GeneCode® and AMZ® brands, we also maintain a small consulting business that provides general business-advisory and administrative support services to third parties.

Written from the business description in VitaNova Life Sciences Corporation's annual report to the U.S. Securities and Exchange Commission, filed 29 July 2026. Every sentence was checked against that document before publication.

Growth

USD 3.0M
Revenue, FY2025 · full 10-year series below
Revenue $M Net income $M
FY2025 · Revenue 3.0 · Net income -0.0
2M3M
2016201920222025
Compound annual growth
+330.2%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−1 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating 0.1% · Net -1.2%
20%40%-20%-40%-60%
201620202025
ROE
FY2025 · ROE -1.9%
20%40%
201620202025
Three returns, three denominators.

Each USD of equity lost 2 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks

Total assetsUSD 2.4M
EquityUSD 2.1M
CashUSD 1.6M
Current ratio6.14×

Equity funds 84% of total assets.

The 10-year record

10 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
VNOV, 10-year financial record
Metric 2025202420232022202120202019201820172016
Revenue $B0.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0◌
EBITDA $B◌◌◌◌◌◌◌−0.0−0.0◌
Income tax $B0.00.00.00.00.00.00.00.00.0◌
Net income $B−0.00.00.0−0.00.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $◌0.030.010.000.02−0.010.000.000.00◌
Dividend / sh $◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————
ROE %−1.957.4————————
Shares out B0.010.030.030.010.010.010.010.010.010.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 2 failures in 42 reconciliationsAUDITED

Reconciled in 9 of the 10 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. 10 checks were skipped: EPS is not tagged before 2017. Nine checks were skipped: revenue is not tagged before 2016.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency2 failures
ActivityWholesale-Apparel, Piece Goods & Notions
Listed onOTC market
Incorporated inNevada
Fiscal year endsApril 30
SEC categorysmaller reporting company
Data on record since2016

Share this section

Download image